June 25, 2019 Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials
June 3, 2019 Collaborative framework for delivering on ways that digital technologies can help to optimize new Parkinson’s treatment trials. Stephenson D …et al. | 5th World Parkinson Congress, Kyoto, Japan
May 22, 2019 Measurement Comparability of Electronic and Paper Administered Visual Analogue Scales: A Review of Published Studies
May 1, 2019 Critical Path for Parkinson’s: Catalyzing Innovation for Parkinson’s Clinical Trials through Data Sharing and Regulatory Science. Stephenson D …et al. | American Academy of Neurology, Philadelphia, PA
April 5, 2019 Muscular Dystrophy Association 2019 Clinical and Scientific Conference Jane Larkindale, Executive Director of D-RSC, attended the Muscular Dystrophy Association Clinical and Scientific Conference in Or
March 17, 2019 Increasing Efficiency, Safety, and Speed in Clinical Trials for Neurodegenerative Diseases | Alzheimer’s Drug Discovery Foundation Conference, Long Beach, CA
February 19, 2019 Delving into the Role of Public Private Partnerships in Shaping the Landscape to Enable Precision Medicine for Neurodegeneration | 7th World CNS Summit, Boston, MA
October 11, 2018 Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome (PRO) Measures by Participants with Chronic Obstructive Pulmonary Disease (COPD): Quantitative Interview Findings
November 3, 2018 D-RSC and PSTC presented “Biomarkers for Muscle Diseases” poster at the 2018 MDA Clinical Conference
